Skip to main content

Emicizumab granted priority review for hemophilia A without inhibitors

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
Emicizumab granted priority review for hemophilia A without inhibitors

User login

Username

Password

Reset your password

Type	Lead	score